Based on the anti-atherosclerotic function of S1P demonstrated in vitro and in vivo, the effects of treatment with FTY720 on the development of atherosclerosis were examined in vivo in LDL-R−/− and ApoE−/− mice. This evidence concerns the gene APOE and atherosclerosis.